Two Sigma Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,300
| Closed | -$221K | – | 3773 |
|
|
2020
Q2 | $221K | Sell |
12,300
-774,601
| -98% | -$10.8M | ﹤0.01% | 2584 |
|
|
2020
Q1 | $5.61M | Buy |
786,901
+345,549
| +78% | +$4.31M | 0.05% | 451 |
|
|
2019
Q4 | $10.5M | Sell |
441,352
-109,840
| -20% | -$3.03M | 0.03% | 597 |
|
|
2019
Q3 | $14.8M | Buy |
551,192
+1,835
| +0.3% | +$51.5K | 0.05% | 426 |
|
|
2019
Q2 | $14.9M | Buy |
549,357
+538,444
| +4,934% | +$16.9M | 0.05% | 437 |
|
|
2019
Q1 | $379K | Sell |
10,913
-98,572
| -90% | -$2.84M | ﹤0.01% | 2444 |
|
|
2018
Q4 | $2.14M | Buy |
+109,485
| New | +$2.25M | 0.01% | 1208 |
|
|
2018
Q1 | – | Sell |
-203,469
| Closed | -$9.9M | – | 3697 |
|
|
2017
Q4 | $9.9M | Sell |
203,469
-109,585
| -35% | -$5.54M | 0.03% | 611 |
|
|
2017
Q3 | $16.9M | Sell |
313,054
-63,729
| -17% | -$3.74M | 0.06% | 362 |
|
|
2017
Q2 | $21.2M | Buy |
376,783
+320,196
| +566% | +$12.8M | 0.08% | 314 |
|
|
2017
Q1 | $2.22M | Buy |
+56,587
| New | +$1.8M | 0.01% | 1397 |
|
|
2016
Q2 | – | Sell |
-96,564
| Closed | -$1.97M | – | 3385 |
|
|
2016
Q1 | $1.97M | Buy |
96,564
+29,599
| +44% | +$939K | 0.01% | 1193 |
|
|
2015
Q4 | $3.44M | Buy |
+66,965
| New | +$3.25M | 0.02% | 817 |
|
|
2015
Q2 | – | Sell |
-188,542
| Closed | -$7.16M | – | 3219 |
|
|
2015
Q1 | $7.16M | Buy |
188,542
+175,403
| +1,335% | +$6.03M | 0.03% | 581 |
|
|
2014
Q4 | $372K | Buy |
+13,139
| New | +$365K | ﹤0.01% | 1844 |
|
|
2014
Q3 | – | Sell |
-19,416
| Closed | -$567K | – | 2183 |
|
|
2014
Q2 | $567K | Buy |
+19,416
| New | +$470K | ﹤0.01% | 1552 |
|
|
2014
Q1 | – | Sell |
-23,044
| Closed | -$593K | – | 2373 |
|
|
2013
Q4 | $593K | Buy |
+23,044
| New | +$560K | ﹤0.01% | 1590 |
|
Two Sigma Investments's PTLA Position: Q3 2020 in Review
Two Sigma Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 12,300 shares — an estimated $221K sold.
Two Sigma Investments first reported a position in PTLA in Q4 2013 and held it in 17 quarters. The position peaked at $21.2M in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Two Sigma Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Two Sigma Investments sold 12,300 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $221K.
- Two Sigma Investments first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 17 quarters.
- Two Sigma Investments's Portola Pharmaceuticals, Inc. position peaked at $21.2M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Two Sigma Investments's 13F filing for Q3 2020, filed 16 Nov 2020.